Efficacy of AlbenDazole to inDuce mUcosal healing in Patients with Crohn’s diseaseon anti-TNF monotherapy:ADD UP trial
- Conditions
- Crohn's disease
- Registration Number
- NL-OMON20630
- Lead Sponsor
- Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands
- Brief Summary
A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 110
Inclusion Criteria
•Patients ≥18 years and ≤65 years
•Diagnosis of CD, based on endoscopy and histopathologic examination of mucosal biopsies
Exclusion Criteria
•Ulcerative colitis or indeterminate colitis
•Current malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method •Proportion of patients with absence of ulcers on centrally read endoscopies after 12 weeks of albendazole and anti-TNF combination treatment compared to placebo
- Secondary Outcome Measures
Name Time Method